Epitope selection and design of synthetic vaccines. Molecular approaches to enhancing immunogenicity and cross-reactivity of engineered vaccines.
about
An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positionsDNA vaccines: developing new strategies against cancer.Strategies to use immune modulators in therapeutic vaccines against cancerProgress on new vaccine strategies for the immunotherapy and prevention of cancer.Strategies for designing and optimizing new generation vaccines.Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses.Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequenceTARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer.F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopesInduction of Specific CD8 T Cells against Intracellular Bacteria by CD8 T-Cell-Oriented Immunization Approaches.Cancer vaccine strategies: translation from mice to human clinical trials.
P2860
Q27485984-37065760-EB13-47BE-932C-C419E38B4664Q30448796-3FBB9968-C13F-460A-9F0F-4693A746724FQ33756622-1917B15A-074C-421C-80F5-5C0DF7520B5CQ34275601-5BDE6FC1-2F4E-4B4A-9066-C0138FC60E98Q34328457-BCD7915C-26FA-4D82-A7B7-A9C7714E7811Q34572198-118FB7E9-0377-4E12-B2A8-31F370B3CE78Q36470715-8FC8EEDF-462B-4157-86B5-C7DCA8BBBF45Q36597984-DAB3E863-B288-4F7C-801C-2313C9BBEB99Q37224581-841F6012-0A01-4521-BA91-C353256FD4E1Q37360991-EEBDD977-BB99-43B3-8AA2-B7F55AC920F7Q40730694-A10747D0-9E51-4079-A981-C43C8C48B038Q48295639-DFB8B23D-846D-418D-A1F5-8FF4DA644CA2
P2860
Epitope selection and design of synthetic vaccines. Molecular approaches to enhancing immunogenicity and cross-reactivity of engineered vaccines.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Epitope selection and design o ...... tivity of engineered vaccines.
@en
type
label
Epitope selection and design o ...... tivity of engineered vaccines.
@en
prefLabel
Epitope selection and design o ...... tivity of engineered vaccines.
@en
P2860
P1476
Epitope selection and design o ...... tivity of engineered vaccines.
@en
P2093
Berzofsky JA
P2860
P304
P356
10.1111/J.1749-6632.1993.TB44014.X
P407
P577
1993-08-01T00:00:00Z